HIGHLIGHTS
- who: Borje S. Andersson from the (UNIVERSITY) have published the article: A randomized phase III study of pretransplant conditioning for AML/MDS with fludarabine and once daily IV busulfanu00e2u20acu2030u00b1u00e2u20acu2030clofarabine in allogeneic stem cell transplantation, in the Journal: (JOURNAL) of 24/05/2022
- what: There was no meaningful difference between FCB and Flu-Bu in either PFS or OS for the entire population, but a substantive superiority of FCB in NCR patients or patients with age u226460.
- future: This may be investigated in a future study to obtain confirmatory results and application of FCB . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.